These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1721407)
1. Effect of FK 506 on experimental liver carcinogenesis. Shinozuka H; Warty VS; Masuhara M; Murase N; Iwatsuki S Transplant Proc; 1991 Dec; 23(6):3197-9. PubMed ID: 1721407 [No Abstract] [Full Text] [Related]
2. Expression of a 65-kDa tumor-associated protein and persistence of altered hepatic foci. Hanausek M; Sherman U; Adams AK Prog Clin Biol Res; 1991; 369():91-103. PubMed ID: 1946546 [No Abstract] [Full Text] [Related]
3. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay. Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881 [TBL] [Abstract][Full Text] [Related]
4. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver. Fukushima S; Wanibuchi H; Morimura K; Nakae D; Tsuda H; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F Cancer Lett; 2005 May; 222(1):11-5. PubMed ID: 15837536 [TBL] [Abstract][Full Text] [Related]
5. [Evolution of hyperplastic foci in the rat liver induced by diethylnitrosamine]. Gel'shteĭn VI; Chipysheva TA; Bannikov GA Eksp Onkol; 1984; 6(1):17-22. PubMed ID: 6209086 [TBL] [Abstract][Full Text] [Related]
6. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Neveu MJ; Hully JR; Paul DL; Pitot HC Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356 [TBL] [Abstract][Full Text] [Related]
7. Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. Gerbracht U; Eigenbrodt E; Simile MM; Pascale RM; Gaspa L; Daino L; Seddaiu MA; De Miglio MR; Nufris A; Feo F Anticancer Res; 1993; 13(6A):1965-72. PubMed ID: 8297102 [TBL] [Abstract][Full Text] [Related]
8. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay. Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917 [TBL] [Abstract][Full Text] [Related]
9. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine. Waddell WJ; Fukushima S; Williams GM Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687 [TBL] [Abstract][Full Text] [Related]
10. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment. Moolgavkar SH; Luebeck EG Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095 [No Abstract] [Full Text] [Related]
11. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats. Fukushima S; Hagiwara A; Hirose M; Yamaguchi S; Tiwawech D; Ito N Jpn J Cancer Res; 1991 Jun; 82(6):642-9. PubMed ID: 1906850 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil. Ghia M; Mereto E; Cavanna M; Brambilla G Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693 [TBL] [Abstract][Full Text] [Related]
13. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of rat liver cell foci development by combined treatment with heterocyclic amines at low doses. Ito N; Hasegawa R; Asakawa E; Hirose M; Imaida K; Hagiwara A Princess Takamatsu Symp; 1995; 23():251-9. PubMed ID: 8844816 [TBL] [Abstract][Full Text] [Related]
15. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418 [TBL] [Abstract][Full Text] [Related]
17. Medium-term carcinogenicity bioassay. Della Porta G Jpn J Cancer Res; 1992 Aug; 83(8):inside front cover. PubMed ID: 1399815 [No Abstract] [Full Text] [Related]
18. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator. Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854 [TBL] [Abstract][Full Text] [Related]
19. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Takada N; Matsuda T; Otoshi T; Yano Y; Otani S; Hasegawa T; Nakae D; Konishi Y; Fukushima S Cancer Res; 1994 Jun; 54(11):2895-9. PubMed ID: 8187074 [TBL] [Abstract][Full Text] [Related]
20. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse. Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733 [No Abstract] [Full Text] [Related] [Next] [New Search]